choipharm
Pioneering advancements in drug research and development, from formulation to regulatory compliance.
Pioneering advancements in drug research and development, from formulation to regulatory compliance.
ChoiPharm is a biotechnology and pharmaceutical startup focused on pioneering advancements in drug research and development. Founded in 2017, the company is dedicated to various aspects of the pharmaceutical industry, including new product development for generic drugs, consistency evaluation, process development for APIs and intermediates, production and management solutions, raw material drug DMF filing, as well as comprehensive registration consulting and services. The company secured a significant CNY3.00M in an Angel Round investment on 07 March 2017. The investment was made by key firms such as JD Capital, Tongxi Capital, Homsun Capital, Shenzhen Xinhaisheng Investment, Haikou Kundian Touzi Zixun Youxian Gongsi, and Shoutai Touzi Jituan Youxian Gongsi. ChoiPharm's slogan "Pioneering advancements in drug research and development, from formulation to regulatory compliance," reflects its commitment to innovation and compliance in the pharmaceutical sector. With a strong focus on technology-driven advancements, ChoiPharm is poised for significant growth and impact in the healthcare and pharmaceutical industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Angel Round | CNY3.00M | 6 |
|
07 Mar 2017 |
No recent news or press coverage available for choipharm.
We care about your data, and we'd love to use cookies make your experience better.